Irla, N; Schneiter, T; Haneke, E; Yawalkar, N (2010). Nail Lichen Planus: Successful Treatment with Etanercept. Case reports in dermatology, 2(3), pp. 173-176. Basel: Karger
|
Text
000321419.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (953kB) | Preview |
BACKGROUND: Etanercept is a fully human tumor necrosis factor a receptor fusion protein that binds tumor necrosis factor a with greater affinity than natural receptors. Biologics are widely used in the treatment of psoriasis and psoriasis arthritis and may represent a new therapeutic option for some patients with psoriatic nail disease. CASE REPORT: We report a case of lichen planus limited to the toe nails successfully treated with etanercept monotherapy. CONCLUSION: The significant improvement of our case suggests that etanercept is an effective treatment modality for lichen planus limited particularly to the nails. Further controlled studies are needed to establish the effectiveness and therapeutic regimes.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Irla, Nathalie, Schneiter, Thomas, Haneke, Eckart, Yawalkar, Nikhil |
ISSN: |
1662-6567 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:12 |
Last Modified: |
25 May 2023 13:57 |
PubMed ID: |
21113341 |
BORIS DOI: |
10.48350/2273 |
URI: |
https://boris.unibe.ch/id/eprint/2273 (FactScience: 204665) |
Actions (login required)
 |
Edit item |